Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

4 key takeaways from ISC 2023: AFib detection, improved stroke survival and more

Leading stroke specialists from all over the world gathered in Dallas for the 2023 International Stroke Conference. Catch up on some of the biggest stories that came out of the three-day event. 

Thumbnail

Abbott to acquire vascular disease specialists for $890M

Minnesota-based Cardiovascular Systems Inc. is perhaps best known for its atherectomy devices designed to treat PAD and CAD.

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

TAVR and PAD: What cardiologists need to know

TAVR patients presenting with peripheral artery disease face significantly higher in-hospital risks, according to a new study published in Current Problems in Cardiology

A key step forward: Researchers ID the genes responsible for CAD

The team hopes its findings can lead to significant progress in the war against fatty plaques.

Thumbnail

Coronary IVL now recommended at all cath labs, even those without surgical backup

The latest SCAI guidance on the safety of PCI procedures included a key change that could expand coronary IVL utilization throughout the United States. 

Thumbnail

Why are post-TAVR stroke rates higher at comprehensive stroke centers?

One of the more likely reasons is simple: specialty centers have better tools for identifying signs of stroke.

Thumbnail

Why more pulmonary embolism patients should be considered for surgery

The topic was explored at length in a new scientific statement presented at the 59th Annual Meeting of the Society of Thoracic Surgeons.

Increased use of CCTA improves CAD outcomes without raising costs

Researchers examined data from nearly 2 million patients, sharing their full findings in JACC: Cardiovascular Imaging.